Vectorite Biomedical Stock

Vectorite Biomedical EBIT Margin

The EBIT Margin (Operating Margin) of Vectorite Biomedical (4170.TWO) as of Jul 21, 2026 is -44.96 %. In the previous year, EBIT Margin (Operating Margin) was -28.88 % — a change of 55.66% (lower).

EBIT Margin

-44.96 %

YoY

55.66%

Last updated:

EBIT Margin (Operating Margin) of Vectorite Biomedical is 2026 -44.96 % . EBIT Margin (Operating Margin) of Vectorite Biomedical was 2025 -28.88 % . It decreases by 55.66% lower compared to the previous year.

For Vectorite Biomedical, the operating (EBIT) margin of -45.0% is up versus -248.2% a few years ago.

Access this data via the Eulerpool API

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

EBIT Margin (Operating Margin) of Vectorite Biomedical is -44.96 % in 2026.

Access this data via the Eulerpool API

Margins — Vectorite Biomedical

All Key Metrics — Vectorite Biomedical